ArticleVaccine: X2024

Why did I participate in an HIV vaccine study? Experiences of participation in the first phase II HIV vaccine trial in Mozambique: An ancillary study using a mixed-method approach.

Igor P Ubisse Capitine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.